Joint Active Systems (JAS) is an international company specializing in range of motion treatment options for patients with joint stiffness and limited range of motion. Their products, including Static Progressive Stretch (SPS) and Dynamic Splint (DS), aim to restore physical function and improve the quality of life for individuals affected by injury, surgery, or disease. With over 30 clinical studies published in peer-reviewed medical journals, JAS has demonstrated successful results in the field. The company was founded in 1992 and operates within the Health Care and Manufacturing industries.
Based in Effingham, IL, JAS manufactures and distributes its range of motion treatment options globally. Though specific details are not available regarding the last investment or the parties involved, JAS continues to make strides in the industry, providing crucial solutions for individuals in need of advanced care and treatment. With a proven track record and a focus on innovation, JAS presents a promising opportunity for potential investors seeking to support impactful advancements in healthcare and manufacturing.